Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-26,220
Closed -$987K 272
2015
Q3
$987K Sell
26,220
-620
-2% -$25.4K 0.02% 129
2015
Q2
$1.3M Buy
26,840
+22,700
+548% +$1.17M 0.02% 131
2015
Q1
$207K Buy
4,140
+425
+11% +$23K ﹤0.01% 237
2014
Q4
$243K Sell
3,715
-2,890
-44% -$201K ﹤0.01% 213
2014
Q3
$503K Buy
6,605
+160
+2% +$13.2K 0.01% 181
2014
Q2
$531K Sell
6,445
-473
-7% -$35.2K 0.01% 175
2014
Q1
$486K Sell
6,918
-554
-7% -$38K 0.01% 178
2013
Q4
$536K Sell
7,472
-23
-0.3% -$1.67K 0.02% 151
2013
Q3
$528K Buy
7,495
+1,109
+17% +$74.2K 0.02% 122
2013
Q2
$397K Buy
+6,386
New +$394K 0.02% 129

Other funds holding NOV

Salient Capital Advisors's NOV Position: Q4 2015 in Review

Salient Capital Advisors sold out of NOV (NOV) in Q4 2015, closing a stake of 26,220 shares — an estimated $987K sold.

Salient Capital Advisors first reported a position in NOV in Q2 2013 and held it in 10 quarters. The position peaked at $1.3M in Q2 2015. 685 funds tracked by Wall St. Rank hold NOV as of Q4 2015.

  • Salient Capital Advisors reported no remaining NOV position as of Q4 2015 after selling out during the quarter.
  • Salient Capital Advisors sold 26,220 NOV shares in Q4 2015, an estimated $987K.
  • Salient Capital Advisors first reported a position in NOV in Q2 2013 and held it in 10 quarters.
  • Salient Capital Advisors's NOV position peaked at $1.3M in Q2 2015.
  • 685 funds tracked by Wall St. Rank held NOV as of Q4 2015.

Based on Salient Capital Advisors's 13F filing for Q4 2015, filed 11 Feb 2016.